Angion Reports Positive Results from Phase 1 Healthy Volunteer Study for ANG-3070 and FDA Authorization to Initiate Phase 2 Trial in 2021
ANG-3070 was well-tolerated across dose cohorts, achieving drug exposures in humans exceeding exposures in which…
Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion